A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins-Reference-Cited by-同舟云学术

A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins

Published:2005-02-15 Issue:4 Volume:11 Page:1474-1482
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Idenoue Satomi,Hirohashi Yoshihiko,Torigoe Toshihiko,Sato Yuriko,Tamura Yasuaki,Hariu Hiroyuki,Yamamoto Masaaki,Kurotaki Takehiro,Tsuruma Tetsuhiro,Asanuma Hiroko,Kanaseki Takayuki,Ikeda Hideyuki,Kashiwagi Kiyoteru,Okazaki Minoru,Sasaki Kazuaki,Sato Takashi,Ohmura Tousei,Hata Fumitake,Yamaguchi Koji,Hirata Koichi,Sato Noriyuki

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11

2. Alpha/beta-defensins influence on the humoral immunity and complications in cancer of the oral cavity and oropharynx;Immunotherapy;2024-08-19

3. Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma;Clinical Cancer Research;2023-09-22

4. Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications;International Journal of Molecular Sciences;2023-07-23

5. Insight on common forms of cutaneous head and neck carcinoma (Review);Molecular and Clinical Oncology;2023-02-17